| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/19/2005 | US6918281 Gas sensor calibration system |
| 07/19/2005 | CA2456313A1 Spacially addressable protein capture array |
| 07/16/2005 | CA2487467A1 Gas-measuring device with an electrochemical sensor |
| 07/16/2005 | CA2481169A1 Method and instrument for characterizing treading surfaces, for instance for realizing synthetic turf surfaces |
| 07/14/2005 | WO2005064639A2 Fabricating a set of semiconducting nanowires, and electric device comprising a set of nanowires |
| 07/14/2005 | WO2005064473A1 Safety test support system, method, and program |
| 07/14/2005 | WO2005064349A2 Detection cartridges, modules, systems and methods |
| 07/14/2005 | WO2005064347A1 Reducing time to result for blood bank diagnostic testing |
| 07/14/2005 | WO2005064346A2 Use of anti-parafibromin antibodies to diagnose hyperparathyroidism-jaw tumor syndrome (hpt-jt) and parathyroid cancer |
| 07/14/2005 | WO2005064345A2 Methods and systems for protein and peptide evidence assembly |
| 07/14/2005 | WO2005064344A1 Method of predicting abnormality of lipid metabolism |
| 07/14/2005 | WO2005064343A1 Biomarkers for sensitivity of proliferative diseases to mtor inhibitors |
| 07/14/2005 | WO2005064342A1 An assay chip, and uses of said assay chip to determine molecular structures and functions |
| 07/14/2005 | WO2005064341A2 Methods for the in vitro diagnosis and in vitro prognosis of demyelinating diseases, and for the development of drugs against demyelinating diseases |
| 07/14/2005 | WO2005064340A2 Method for serological diagnosis and determination of immunisation status, comprising various controls |
| 07/14/2005 | WO2005064338A1 Microparticles for use in diagnostic methods |
| 07/14/2005 | WO2005064337A1 Optical nanowire biosensor based on energy transfer |
| 07/14/2005 | WO2005064336A1 Pyrenyloxysulfonic acid fluorescent agents |
| 07/14/2005 | WO2005064335A2 Method and device for marking biomolecules |
| 07/14/2005 | WO2005064333A1 Method of analyzing interaction between protein and sugar chain |
| 07/14/2005 | WO2005064332A1 Highly active lysophosphatidic acid and method of screening therewith |
| 07/14/2005 | WO2005064331A1 Method and kit for pesticide analysis |
| 07/14/2005 | WO2005064330A1 Improved matrix with noise reduction additive and disposable target containing the same |
| 07/14/2005 | WO2005064329A1 Method and arrangement for determining constituents in water |
| 07/14/2005 | WO2005064328A1 Method for the photometric determination of a parameter |
| 07/14/2005 | WO2005064327A1 Sugar chain structure profiling technique |
| 07/14/2005 | WO2005064310A1 Method and device for measuring the texture of cooked grains |
| 07/14/2005 | WO2005064307A2 Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6 |
| 07/14/2005 | WO2005064016A1 Method of multiplex microorganism detection |
| 07/14/2005 | WO2005064014A1 Method for the identification of compounds modulating reverse transport of cholesterol |
| 07/14/2005 | WO2005064011A1 Nucleic acid composite materials made sensors for the analysis of nucleic acid modifying factors |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same |
| 07/14/2005 | WO2005063983A1 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/14/2005 | WO2005063982A1 Method of detecting target substance |
| 07/14/2005 | WO2005063978A1 Fraction and antibody comprising guinea pig immunoglobulin e |
| 07/14/2005 | WO2005063976A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | WO2005063973A1 Methods and kits for predicting an infectious disease state |
| 07/14/2005 | WO2005063966A2 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells |
| 07/14/2005 | WO2005063962A1 System for comminuting, extracting and detecting analytes in sold biological samples |
| 07/14/2005 | WO2005063817A2 Methods for identifying functional antibodies |
| 07/14/2005 | WO2005063810A1 Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor |
| 07/14/2005 | WO2005063803A1 Polypeptides for the diagnosis and therapy of leishmaniasis |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063796A1 Inhibitors of amyloid precursor protein processing |
| 07/14/2005 | WO2005063745A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 07/14/2005 | WO2005063612A1 Fine metal structure, process for producing the same, fine metal mold and device |
| 07/14/2005 | WO2005063412A1 Method for coating a surface |
| 07/14/2005 | WO2005063335A2 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS |
| 07/14/2005 | WO2005063286A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | WO2005063220A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | WO2005063170A2 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 07/14/2005 | WO2005063009A1 A procedure for screening of neuroactive substance and the associated neural plasticity |
| 07/14/2005 | WO2005062982A2 Signal amplification methods for analyte detection |
| 07/14/2005 | WO2005062979A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | WO2005062977A2 Prostate cancer specific internalizing human antibodies |
| 07/14/2005 | WO2005062972A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | WO2005062967A2 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | WO2005062952A2 Compositions and methods for modulating sirtuin activity |
| 07/14/2005 | WO2005062918A2 Methods of treating asthma |
| 07/14/2005 | WO2005062916A2 Methods for generating multimeric molecules |
| 07/14/2005 | WO2005062865A2 Optically encoded particles with grey scale spectra |
| 07/14/2005 | WO2005062849A2 Lifespan management |
| 07/14/2005 | WO2005062844A2 System and methods for non-targeted processing of chromatographic data |
| 07/14/2005 | WO2005062788A2 Prostate specific proteins expressed in cancer and methods of use thereof |
| 07/14/2005 | WO2005062780A2 In vivo odorant receptor systems and their uses |
| 07/14/2005 | WO2005062770A2 Method for conducting pharmacogenomics-based studies |
| 07/14/2005 | WO2005062708A2 An assay for the detection of rapamycin and rapamycin analogs |
| 07/14/2005 | WO2005062706A2 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 07/14/2005 | WO2005056043A3 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 07/14/2005 | WO2005053505A3 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 07/14/2005 | WO2005052571A3 System for the generation of a reference gas by the evaporation of a liquid in said gas |
| 07/14/2005 | WO2005049636A3 Method of analyzing protein |
| 07/14/2005 | WO2005049579A3 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/14/2005 | WO2005049066A3 Use of dudulin2 for the treatment or prophylaxis of lung cancer |
| 07/14/2005 | WO2005047873A3 Device and method for the qualitative and/or quantitative analysis of constituents in liquids, especially in drinks and process liquids |
| 07/14/2005 | WO2005047519A3 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas |
| 07/14/2005 | WO2005044429A3 Reagent-containing membranes and laminates and methods of their prepration |
| 07/14/2005 | WO2005040422A3 Differentially expressed genes related to coronary artery disease |
| 07/14/2005 | WO2005040073A3 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids |
| 07/14/2005 | WO2005031000A3 Treating neuropathic pain with neuropeptide ff receptor 2 agonists |
| 07/14/2005 | WO2005024377A3 Assay for detecting changes in mitochondrial membrane integrity and method of using same |
| 07/14/2005 | WO2005023816A3 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof |
| 07/14/2005 | WO2005017187A3 Methods for screening and identifying compounds |
| 07/14/2005 | WO2005012899A3 Method for error detection and increased confidence of sample decoding |
| 07/14/2005 | WO2005012502A3 Methods of identifying optimal variants of peptide epitopes |
| 07/14/2005 | WO2005012350A3 Epha2 t-cell epitope agonists and uses therefor |
| 07/14/2005 | WO2005005933A8 Method of marking a product, marked product resulting thereof, and method of identifying same |
| 07/14/2005 | WO2005003723A3 Method for uniform application of fluid into a reactive reagent area |
| 07/14/2005 | WO2004113921A9 Reagent for assaying anti-treponema pallidum antibody and method of assaying anti-treponema pallidum antibody |
| 07/14/2005 | WO2004108765A3 Extracellular aspergillus polypeptides |
| 07/14/2005 | WO2004103394A3 Method and compositions for nerve regeneration |
| 07/14/2005 | WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| 07/14/2005 | WO2004086033A3 Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 6(edg6) |
| 07/14/2005 | WO2004069983A3 Microreactor architecture and methods |
| 07/14/2005 | WO2004059322A8 Prp detection method using an ancillary macrocyclic ligand |
| 07/14/2005 | WO2004056855A9 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
| 07/14/2005 | WO2004030521A3 Use of biomarkers for detecting acute renal transplant rejection |
| 07/14/2005 | WO2004023981A3 Methods and compositions for blood pool identification, drug distribution quantification and drug release verification |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |